![Ton Logtenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ton Logtenberg
Président chez Synox Therapeutics Ltd.
Postes actifs de Ton Logtenberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
Utrecht Science Park | Directeur/Membre du Conseil | 01/11/2014 | - |
Jenner Vaccine Foundation | Directeur/Membre du Conseil | 01/01/2008 | - |
Hubrecht Organoid Technology Foundation | Directeur/Membre du Conseil | 01/08/2018 | - |
Synox Therapeutics Ltd.
![]() Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Président | 27/07/2021 | - |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Private Equity Investor | 31/03/2022 | - |
Mestag Therapeutics Ltd.
![]() Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Président | 20/12/2022 | - |
Directeur/Membre du Conseil | 01/01/2022 | 20/12/2022 |
Historique de carrière de Ton Logtenberg
Anciens postes connus de Ton Logtenberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
MERUS N.V. | Directeur/Membre du Conseil | 16/06/2003 | 31/12/2019 |
Directeur Général | 16/06/2003 | 31/12/2019 | |
Directeur Financier/CFO | - | 31/12/2019 | |
Fondateur | 16/06/2003 | 31/12/2019 | |
President | 16/06/2003 | 31/12/2019 | |
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Directeur Technique/Scientifique/R&D | 01/07/2000 | 01/11/2003 |
Fondateur | 01/07/2000 | 01/11/2003 | |
FORN EUROPAR | Directeur/Membre du Conseil | - | - |
Independent Dir/Board Member | - | - | |
░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Ton Logtenberg
University of Utrecht | Doctorate Degree |
Statistiques
Internationale
Pays-Bas | 6 |
Royaume-Uni | 3 |
Irlande | 2 |
Opérationnelle
Director/Board Member | 6 |
Founder | 2 |
Chairman | 2 |
Sectorielle
Health Technology | 4 |
Finance | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MERUS N.V. | Health Technology |
Entreprise privées | 8 |
---|---|
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Utrecht Science Park | |
Jenner Vaccine Foundation | |
Hubrecht Organoid Technology Foundation | |
Synox Therapeutics Ltd.
![]() Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Health Technology |
Forbion European Acquisition Corp.
![]() Forbion European Acquisition Corp. Financial ConglomeratesFinance Forbion European Acquisition Corp. is a blank check company. It engages in the business of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded by Hugo Alexander Slootweg in 2006 and is headquartered in Wilmington, DE. | Finance |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
Mestag Therapeutics Ltd.
![]() Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Finance |
- Bourse
- Insiders
- Ton Logtenberg
- Expérience